Iron use among erythropoietin-treated US hemodialysis patients

被引：0
|
作者：
Young, EW
Bloembergen, WE
Woods, JD
Emmert, G
Port, FK
Wolfe, RA
Jones, CA
Held, PJ
机构：
[1] US RENAL DATA SYST, ANN ARBOR, MI USA
[2] VAMC, ANN ARBOR, MI USA
[3] UNIV MICHIGAN, ANN ARBOR, MI 48109 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A1102 / A1102
页数：1
相关论文
共 50 条
  • [1] LOW IRON-ABSORPTION IN ERYTHROPOIETIN-TREATED HEMODIALYSIS-PATIENTS
    KOOISTRA, MP
    VANES, A
    STRUYVENBERG, A
    MARX, JJM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 543 - 543
  • [2] Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients
    Chiang, WC
    Tsai, TJ
    Chen, YM
    Lin, SL
    Hsieh, BS
    [J]. CLINICAL NEPHROLOGY, 2002, 58 (05) : 363 - 369
  • [3] Anemia severity and missed dialysis treatments in erythropoietin-treated hemodialysis patients
    Ifudu, O
    Chan, E
    Paul, H
    Mayers, JD
    Cohen, LS
    Brezsnyak, WF
    Herman, AI
    Avram, MM
    Friedman, EA
    [J]. ASAIO JOURNAL, 1996, 42 (03) : 146 - 149
  • [4] Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium
    Kooistra, MP
    Niemantsverdriet, EC
    van Es, A
    Mol-Beermann, NM
    Struyvenberg, A
    Marx, JJM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (01) : 82 - 88
  • [5] Predictors of target hematocrit among erythropoietin-treated HD patients.
    Young, EW
    Woods, JD
    Segieda, GE
    Held, PJ
    Port, FK
    Bloembergen, WE
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1192 - A1192
  • [6] The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients
    Kooistra, MP
    Marx, JJM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2578 - 2582
  • [7] Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants
    Pollak, A
    Hayde, M
    Hayn, M
    Herkner, K
    Lombard, KA
    Lubec, G
    Weninger, M
    Widness, JA
    [J]. PEDIATRICS, 2001, 107 (01) : 78 - 85
  • [8] Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients
    Drueke, TB
    Barany, P
    Cazzola, M
    Eschbach, JW
    Grutzmacher, P
    Kaltwasser, JP
    Macdougall, IC
    Pippard, MJ
    Shaldon, S
    vanWyck, D
    [J]. CLINICAL NEPHROLOGY, 1997, 48 (01) : 1 - 8
  • [9] CLINICAL AND BLOOD RHEOLOGIC STABILITY IN ERYTHROPOIETIN-TREATED PREDIALYSIS PATIENTS
    BROWN, CD
    FRIEDMAN, EA
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 : 29 - 33
  • [10] EFFECT OF NORMAL V ANEMIC HEMATOCRIT ON AMBULATORY BLOOD-PRESSURE (ABP) IN ERYTHROPOIETIN-TREATED HEMODIALYSIS (HD) PATIENTS
    BERNS, JS
    RUDNICK, MR
    COHEN, RM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 520 - 520
12345